Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever.

…, U Kalyoncu, O Karadag, M Hayran, AI Ertenli… - The Journal of …, 2007 - jrheum.org
OBJECTIVE: Colchicine is a mainstay of treatment in familial Mediterranean fever (FMF);
however, 5%-10% of patients do not respond to colchicine. Adenosine triphosphate-binding …

Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients

…, U Kalyoncu, SA Bilgen, N Ozer, AI Ertenli… - Clinical …, 2007 - Springer
Systemic lupus erythematosus (SLE) is associated with severe and premature cardiovascular
disease, which cannot be explained by traditional risk factors alone. This study aims to …

B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?

…, S Kiraz, S Aksoyek, F Ozmen, AI Ertenli - Clinical …, 2007 - Springer
Cardiovascular disease is a major cause of death in patients with systemic lupus erythematosus
(SLE) especially during the late phase of the disease. This study was conducted to …

Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis

…, O Karadag, A Akdogan, MA Ozturk, S Kiraz, I Ertenli… - Joint bone spine, 2008 - Elsevier
AIMS: The aim of this retrospective study was to investigate the correlation between MPV
and the clinical disease activity indices of rheumatoid arthritis and ankylosing spondylitis. …

Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab

…, B Kisacik, M Erman, S Erguven, AI Ertenli - … journal of infectious …, 2007 - Taylor & Francis
Patients with rheumatoid arthritis (RA) have an increased risk of infection as a result of
alterations in immune regulation, debility, and comorbid illnesses. TNF-α is of central importance …

The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet's disease. A randomized clinical trial

M Çalgüneri, S Kiraz, I Ertenli, M Benekli… - Arthritis & …, 1996 - Wiley Online Library
Objective. Because exposure to streptococcal antigens might be a major disease activity—provoking
factor in Behçet's disease, this study was undertaken to evaluate the effectiveness …

A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis

…, M Kalyoncu, İ Şimşek, E Beyan, İ Ertenli… - Clinical …, 2006 - Springer
Adult-onset Still’s disease (AOSD) has often been regarded as the adult spectrum of systemic
juvenile idiopathic arthritis (sJIA). The present study aims to compare the clinical and …

Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: data from a large multicenter cohort

…, E Erken, M Turgay, A Cefle, I Ertenli… - Journal of …, 2016 - Elsevier
Background Adult-onset Still's disease (AOSD) is a rare condition, and treatment choices
are frequently dependent on expert opinions. The objectives of the present study were to …

Pathological haemostasis and 'prothrombotic state'in Behçet's disease

S Kiraz, I Ertenli, MA Öztürk, IC Haznedaroğlu… - Thrombosis research, 2002 - Elsevier
Behçet's disease (BD) is a widespread occlusive-type vasculitis with life-threatening manifestations.
The vasculopathy of BD is unique and any type of vessel can be involved. Moreover, …

Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome)

…, Z Ozbalkan, MA Ozturk, S Apras, AI Ertenli… - Clinical …, 2006 - Springer
The objective of this study is to evaluate the efficacy, toxicity, and long-term outcome of low-dose
IV cyclophosphamid therapy with repeated frequent intervals in combination with oral …